Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein

References

1. Ambrose M. W., Wyde P. R., Ewasyshun M., Bonneau A., Caplan B., Meyer H. L., Klein M. 1991; Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats. Vaccine 9:505–511
   [Google Scholar]
2. Bloom H. H., Johnson K. M., Jacobsen R, Chanock R. M. 1961; Recovery of parainfluenza viruses from adults with upper respiratory illness. American Journal of Hygiene 74:50–59
   [Google Scholar]
3. Brideau R. J., Wolcott J. A. 1987; Pyrimidinone mediated alteration of T lymphocytes subsets during murine cytomegalovirus infection. Journal of Clinical Experimental Immunology 68:613–620
   [Google Scholar]
4. Brideau R. J., Wathen M. W. 1991; A chimeric glycoprotein of human respiratory syncytial virus termed FG induces T-cell mediated immunity in mice. Vaccine 9:863–864
   [Google Scholar]
5. Brideau R. J., Walters R. R., Stier M. A., Wathen M. W. 1989; Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein. Journal of General Virology 70:2637–2644
   [Google Scholar]
6. Chanock R. M., McIntosh K. 1990; Parainfluenza viruses. In Virology, 2nd edn. pp. 963–987 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
   [Google Scholar]
7. Clyde W. A., Denny F. W. 1983; Workshop on acute respiratory diseases among children of the world. Pediatric Research 17:1023–1076
   [Google Scholar]
8. Coelingh K. L., Murphy B. B., Collins P. L., Lebacq-Verheyden A. M., Battey J. F. 1989; Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus. Virology 160:465–472
   [Google Scholar]
9. Hall S. L., Murphy B. R., van Wyke Coelingh K. L. 1991; Protection of cotton rats by immunization with the human parainfluenza virus type 3 fusion (F) glycoprotein expressed on the surface of insect cells infected with a recombinant baculovirus. Vaccine 9:659–667
   [Google Scholar]
10. Lehman D. J., Roof L. L., Brideau R. J., Aeed P. A., Thomsen D. R., Elhammer Å. P., Wathen M. W., Homa F. L. 1993; Comparison of soluble and secreted forms of human parainfluenza type 3 virus glycoproteins expressed from mammalian and insect cells as subunit vaccines. Journal of General Virology 74:459–469
    [Google Scholar]
11. Ray R., Glaze B. J., Compans R. W. 1988; Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response. Journal of Virology 62:783–787
    [Google Scholar]
12. Ray R., Galinski M. S., Compans R. W. 1989; Expression of the fusion glycoprotein of human parainfluenza type 3 virus in insect cells by a recombinant baculovirus and analysis of its immunogenic property. Virus Research 12:169–180
    [Google Scholar]
13. Spriggs M. K., Murphy B. R., Prince G. A., Olmsted R. A., Collins P. L. 1987; Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses : contributions of the individual proteins to host immunity. Journal of Virology 61:3416–3423
    [Google Scholar]
14. Wathen M. W., Kakuk T. J., Brideau R. J., Hausknecht E. C, Cole S. L., Zaya R. M. 1991; Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge. Journal of Infectious Diseases 163:477–482
    [Google Scholar]